• 1
    Dreyling MH, MartinezCliment JA, Zheng M, Mao J, Rowley JD, Bohlander SK. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc Natl Acad Sci USA 1996; 93: 48049.
  • 2
    Bohlander SK, Muschinsky V, Schrader K et al. Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients. Leukemia 2000; 14: 939.
  • 3
    Narita M, Shimizu K, Hayashi Y et al. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. Br J Haematol 1999; 105: 92837.
  • 4
    Linder B, Newman R, Jones LK et al. Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. J Mol Biol 2000; 299: 36978.
  • 5
    Wysocka J, Swigut T, Xiao H et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature 2006; 442: 8690.
  • 6
    Greif PA, Tizazu B, Krause A, Kremmer E, Bohlander SK. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 2008; 27: 288696.
  • 7
    Caudell D, Zhang Z, Chung YJ, Aplan PD. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res 2007; 67: 802231.
  • 8
    Mulaw MA, Krause A, Deshpande AJ et al. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia 2012; 26: 10129.
  • 9
    Okada Y, Jiang Q, Lemieux M, Jeannotte L, Su L, Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat Cell Biol 2006; 8: 101724.
  • 10
    Chen L, Deshpande AJ, Banka D et al. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l. Leukemia 2013; 27: 81322.
  • 11
    Vecchi M, Polo S, Poupon V, van de Loo JW, Benmerah A, Di Fiore PP. Nucleocytoplasmic shuttling of endocytic proteins. J Cell Biol 2001; 153: 15117.
  • 12
    Borkhardt A, Haas OA, Strobl W et al. A novel type of Mll/Af10 fusion transcript in a child with acute megakaryocytic leukemia (Aml-M7). Leukemia 1995; 9: 17967.
  • 13
    Brandimarte L, Pierini V, Di Giacomo D et al. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. Blood 2013; 121: 50647.
  • 14
    Lee JW, Liao PC, Young KC et al. Identification of hnRNPH1, NF45, and C14orf166 as novel host interacting partners of the mature hepatitis C virus core protein. J Proteome Res 2011; 10: 452234.
  • 15
    Ennas MG, Sorio C, Greim R et al. The human ALL-1/MLL/HRX antigen is predominantly localized in the nucleus of resting and proliferating peripheral blood mononuclear cells. Cancer Res 1997; 57: 203541.
  • 16
    Yedavalli VSRK, Neuveut C, Chi YH, Kleiman L, Jeang KT. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell 2004; 119: 38192.
  • 17
    Tebar F, Bohlander SK, Sorkin A. Clathrin assembly lymphoid myeloid leukemia (CALM) protein: localization in endocytic-coated pits, interactions with clathrin, and the impact of overexpression on clathrin-mediated traffic. Mol Biol Cell 1999; 10: 2687702.
  • 18
    Takagi M, Nishioka M, Kakihara H et al. Characterization of DNA polymerase from Pyrococcus sp. strain KOD1 and its application to PCR. Appl Environ Microbiol 1997; 63: 450410.
  • 19
    Conway AE, Scotland PB, Lavau CP, Wechsler DS. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis. Blood 2013; 121: 475868.
  • 20
    Ford MGJ, Pearse BMF, Higgins MK et al. Simultaneous binding of PtdIns(4,5)P-2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science 2001; 291: 10515.
  • 21
    Meyerholz A, Hinrichsen L, Groos S, Esk PC, Brandes G, Ungewickell EJ. Effect of clathrin assembly lymphoid myeloid leukemia protein depletion on clathrin coat formation. Traffic 2005; 6: 122534.
  • 22
    Bernard OA, Mauchauffe M, Mecucci C, Vandenberghe H, Berger R. A novel gene, Af-1p, fused to Hrx in T(1,11)(P32, Q23), is not related to Af-4, Af-9 nor Enl. Oncogene 1994; 9: 103945.
  • 23
    So CW, So CKC, Cheung N, Chew SL, Sham MH, Chan LC. The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia 2000; 14: 594601.
  • 24
    Bridge JA, Kanamori M, Ma ZG et al. Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor. Am J Pathol 2001; 159: 4115.
  • 25
    Wechsler DS, Engstrom LD, Alexander BM, Motto DG, Roulston D. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein. Genes Chromosom Cancer 2003; 36: 2636.
  • 26
    Ross TS, Bernard OA, Berger R, Gilliland DG. Fusion of Huntingtin interacting protein 1 to platelet-derived growth factor beta receptor (PDGF beta R) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2). Blood 1998; 91: 441926.
  • 27
    Deshpande AJ, Rouhi A, Lin Y et al. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice. Leukemia 2011; 25: 171827.
  • 28
    Stoddart A, Tennant TR, Fernald AA, Anastasi J, Brodsky FM, Le Beau MM. The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice. Oncogene 2012; 31: 494506.
  • 29
    Engqvist-Goldstein AEY, Kessels MM, Chopra VS, Hayden MR, Drubin DG. An actin-binding protein of the Sla2/Huntingtin interacting protein 1 family is a novel component of clathrin-coated pits and vesicles. J Cell Biol 1999; 147: 150318.
  • 30
    von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosom Cancer 1992; 5: 22734.
  • 31
    Nakamura T, Largaespada DA, Lee MP et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nat Genet 1996; 12: 1548.
  • 32
    Nakamura T. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins. Int J Hematol 2005; 82: 217.
  • 33
    Van Vlierberghe P, van Grotel M, Tchinda J et al. The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia. Blood 2008; 111: 466880.
  • 34
    Takeda A, Sarma NJ, Abdul-Nabi AM, Yaseen NR. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins. J Biol Chem 2010; 285: 1624857.